Healthcare
Live Price
Offline$1.85
-2.33% today
1Y Change
+11.87%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 248 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Positron Corporation (POSC) is a Healthcare stock with a market cap of $30.00M and listed on OTC. The stock last traded around $1.85 and up 11.9% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -21.5%, EPS growth of -270.0%, a dividend yield of 0.0%. What stands out right now is revenue -21.5%, EPS -270.0%, free cash flow -177.3% with operating margin -1962.1% and ROIC -307.5%. Valuation already assumes a fairly strong business story at price/sales 49.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines POSC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
POSC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
POSC Max Drawdown
-33.98%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for POSC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$823.7K
-6.6% YoY
FY Net Income
-$62.1K
+89.6% YoY
Free Cash Flow
-$105.0K
+85.2% YoY
Revenue Growth
-21.5%
EPS Growth
-270.0%
Gross Margin
-384.7%
Net Margin
-1974.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 588K | 735K | 728K | 882K | 824K |
| Gross Profit | -342K | -353K | -82K | 133K | 161K |
| Operating Income | -2M | -1M | -3M | -764K | -62K |
| EBITDA | -2M | -1M | -3M | -568K | -39K |
| Net Income | -2M | -2M | -3M | -595K | -62K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 70K | 101K | 71K | 1M | 28K |
| Total Assets | 2M | 2M | 2M | 2M | 451K |
| Total Liabilities | 2M | 2M | 2M | 342K | 510K |
| Shareholder Equity | -413K | -258K | -121K | 2M | -59K |
| Total Debt | 2M | 2M | 2M | 318K | 463K |
| Net Debt | 2M | 2M | 1M | -1M | 435K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
105K
+83.0% YoY
Capital Expenditures
5
+100.0% YoY
Free Cash Flow
105K
+85.2% YoY
Key ratios
Gross Margin
-384.7%
Operating Margin
-1962.1%
Net Margin
-1974.0%
ROE
-469.0%
Debt / Equity
1.35x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.